K. Commisso

发表

Impact of Biopsy Compliance on Outcomes for Patients on Active Surveillance for Prostate Cancer.

Liying Zhang, L. Klotz, A. F. Ghiam, 2020, The Journal of urology.

Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy.

Hans T. Chung, Liying Zhang, B. McCurdy, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

SABR in High-Risk Prostate Cancer: Outcomes From 2 Prospective Clinical Trials With and Without Elective Nodal Irradiation.

Hans T. Chung, Liying Zhang, P. Cheung, 2019, International journal of radiation oncology, biology, physics.

Stereotactic ablative radiotherapy in the treatment of low and intermediate risk prostate cancer: Is there an optimal dose?

P. Cheung, L. D'alimonte, W. Chu, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Evaluating the tolerability of a simultaneous focal boost to the gross tumour in prostate SABR: a toxicity and quality of life comparison of two prospective trials.

P. Cheung, L. D'alimonte, N. Mittmann, 2020, International journal of radiation oncology, biology, physics.

Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy

E. Fokas, H. He, Musaddeque Ahmed, 2019, Journal of Translational Medicine.

Assessment of Serum microRNA Biomarkers to Predict Reclassification of Prostate Cancer in Patients on Active Surveillance

L. Klotz, N. Fleshner, B. Bapat, 2017, The Journal of urology.

Temporal stability and prognostic biomarker potential of the prostate cancer urine transcriptome.

John D. Watson, P. Boutros, R. Bristow, 2019, Journal of the National Cancer Institute.

Phase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of Life.

Liying Zhang, P. Cheung, L. D'alimonte, 2018, International journal of radiation oncology, biology, physics.

Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials.

P. Cheung, L. D'alimonte, D. Loblaw, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate Cancer.

Liying Zhang, P. Cheung, D. Vesprini, 2016, International journal of radiation oncology, biology, physics.

Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial.

Liying Zhang, M. Haider, J. Murgić, 2018, International journal of radiation oncology, biology, physics.

Two StereoTactic ablative radiotherapy treatments for localized prostate cancer (2STAR): Results from a prospective clinical trial.

Liying Zhang, P. Cheung, W. Chu, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Two versus five stereotactic ablative radiotherapy treatments for localized prostate cancer: A quality of life analysis of two prospective clinical trials.

Liying Zhang, B. McCurdy, P. Cheung, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Adult Urology Oncology: Prostate/Testis/Penis/Urethra Impact of Biopsy Compliance on Outcomes for Patients on Active Surveillance for Prostate Cancer

Liying Zhang, L. Klotz, A. F. Ghiam, 2022 .